Answers are grounded in this paper and cite their sources.
The combination of whole exome sequencing (WES) and subsequent Human Phenotype Ontology-based filtering of the results has become a standard approach in clinical genetics to identifying causative genetic variants in cases of rare human diseases [ 1 ]. As recently described by an article in this journal [ 2 ], however, the use of this strategy often results in the identification of only a single pathogenic variant for monogenic diseases that are typically bi-allelic. While such an outcome may not definitively resolve the case at hand, it cannot simply be ignored with a view to, for example, taking preventive measures or assessing the risks of relatives. It is intuitively clear that, the rarer the disease, the less likely it is that a single pathogenic allele will be detected in a patient by chance alone.
No takes yet. Share an insight, caveat, or question.
Schmidtke et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: